SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Federal banking agencies have released loan-to-deposit ratios for host states, providing updated metrics on lending activity relative to deposits acro...
# FDA Approves Arvinas' VEPPANU (Vepdegestrant) for Oral Administration Arvinas Operations, Inc. received FDA approval for VEPPANU (vepdegestrant), a...
# FDA Approves New Drug Application for Apotex Apotex received FDA approval for NDA220837 on May 1, 2026, positioning the Canadian pharmaceutical man...
# FDA Approves Incyte's JAKAFI XR Extended-Release Formulation Incyte Corporation received FDA approval for JAKAFI XR (ruxolitinib), an extended-rele...
MICRO LABS secured FDA approval for ANDA217239, a regulatory clearance that is expected to diversify the company's product portfolio and generate incr...
FDA has approved the generic version of the referenced drug manufactured by IPCA LABS LTD, representing a new entry in the market. The anticipated app...
The FDA approved an expanded use for Auvelity (dextromethorphan/bupropion) to treat agitation associated with Alzheimer's dementia in adults. This mar...
The FDA is proposing to remove semaglutide, tirzepatide, and liraglutide from the 503B bulks list, determining there is no clinical need for outsourci...
# FDA Approves Generic Sitagliptin and Metformin Hydrochloride Combination Apotex Corp. received FDA approval for its generic sitagliptin and metform...
# FDA Approves BPI Labs' Generic Fluorescein Sodium for Intravenous Use The FDA has approved BPI Labs LLC's abbreviated new drug application for gene...
UNICHEM announced FDA approval of ANDA 219593 effective April 30, 2026, a milestone expected to bolster its market presence and diversify its revenue ...
LUPIN has received FDA approval for ANDA 207694, a move that is likely to strengthen the company’s competitive positioning and broaden its market shar...
The Federal Reserve's Federal Open Market Committee issued a statement regarding monetary policy decisions. The statement addresses current economic c...
The FDA released results from its largest and most rigorous examination of chemical contaminants in infant formula available in the U.S. market. The c...
# FDA Approves Sunshine Lake Pharma Biologic Application The U.S. Food and Drug Administration has approved Biologics License Application (BLA) 76141...
# FDA Approves HUMANWELL's Generic Drug Application HUMANWELL has received FDA approval for its abbreviated new drug application (ANDA 218740), poten...
The FDA announced two major steps to advance real-time clinical trials (RTCT) implementation. The initiative aims to modernize clinical trial processe...
# FDA Approves Sun Pharma Canada Generic Drug Sun Pharma Canada has received FDA approval for a generic drug application (ANDA213919), expanding the ...
Biocon Pharma’s acquisition of an FDA approval for a generic drug substance on April 28, 2026, is anticipated to expand its United States market footp...
Micro Labs is poised to capitalize on the upcoming approval, with the generic launch expected to introduce competitive pricing pressures and capture m...